Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. EVE Health Group Limited (EVE)

EVE Health Group Limited (ASX: EVE) - Share Price and Research

- Current share price for EVE : $0.001

EVE Health Group Limited (EVE, formerly EVE Investments Limited), an ASX-listed company, is a vertically integrated producer of branded nutrition, health and wellness products. The Company has global reach and application to fast-growing markets across Australia and New Zealand, Asia Pacific and North America

Intelligent Investor free trial for buy hold sell stock recommendations

EVE General Information +

ASX Code EVE
Website http://www.evehealthgroup.com.au
Industry/Sector Packaged Foods & Meats
Market Cap ($M) 5
EVE Share Price $0.001
Day High $0.001
Day Low $0.001
Last Close $0.001
EVE Share Price Movement - ( No change )
Prices as at 16:35, 19 Apr 2024
+Security prices are delayed by at least 20 minutes and are indicative only.
Trial Banner Trial Banner Trial Banner
Upsell Banner

EVE Related Research

EVE Health Group Limited (EVE) Upcoming Dividends & Yields

There are no dividends for EVE Health Group Limited (EVE). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

EVE Health Group Limited (EVE) Recent ASX Announcements

Headline Annoucement date/time+ Price at announcement+ Current price+ Price 7D Avg Gain/Loss
Notification of cessation of securities - EVE 2 Apr 2024 8:30AM $0.001 $0.001 $0.001 fallen by 0%
Appendix 4D and Half Year Report 28 Feb 2024 6:52PM $0.001 $0.001 $0.001 fallen by 0%
Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2024 3:06PM $0.001 $0.001 $0.001 fallen by 0%
  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

See all ASX announcements from EVE Health Group Limited (EVE) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

EVE Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2023A -$2.53 -$0.10 -61.50% 0.00 0.00 0.00% 0.0%
2022A -$5.37 -$0.10 62.50% 0.00 0.00 0.00% 0.0%
2021A -$3.63 -$0.10 33.30% 0.00 0.00 0.00% 0.0%

EVE Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2021 A 2022 A 2023 A 2021 A 2022 A 2023 A 2021 A 2022 A 2023 A
The a2 Milk Company (A2M) $4,150M 0.3060 0.0778 0.2575 29.5572 27.4247 21.8085 0.00% 0.00% 0.00%
Bega Cheese (BGA) $1,234M 0.2372 -0.4390 0.5796 22.0588 39.3204 24.8924 1.85% 1.85% 2.47%
EVE Health Group (EVE) $5M -0.6154 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Inghams Group (ING) $1,308M -0.1327 0.0000 0.0230 0.0000 12.0713 11.8002 4.12% 5.68% 5.97%

EVE Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 1.67 0.00
Market 0.53 15.30 1.11 1.01
Sector 0.00 18.00 0.74 1.69

EVE Directors

Name Position Start Date
Mr Gregory William (Bill) Fry Executive Director, Chief Executive Officer, Managing Director 18 Aug 2009
Mr Rodney Andrew Hannington Non-Executive Director 14 Jun 2022
Mr Carlos Jin Non-Executive Director 10 Dec 2019

EVE Health Group Limited (EVE) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
3 Oct 2023 JIN, Carlos Transfer Direct Shares 3,116,202 $0.001 $3,116.202
24 Jun 2022 FRY, Gregory Issued Indirect Shares 52,874,996 $0.001 $52,875.000
24 Jun 2022 COOKE, Alasdair Issued Indirect Shares 162,164,667 $0.001 $162,165.000

See all changes in directors' interest & trades for EVE Health Group Limited (EVE) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

EVE Management

Name Position
Steven Jackson Company Secretary

EVE Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in EVE Health Group Limited (EVE). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
663,638,954 (12.58%) Everhoney Biotech Australia Pty Ltd
507,488,612 (9.62%) Hong Kong Jusheng Bolang Technology Co Limited
348,039,268 (6.60%) Alasdair Cooke

EVE Calendar of Events

Date Event
26 February 2025 Report (Interim)
27 September 2024 Report (Annual)
28 August 2024 Report (Prelim)

FAQs about EVE Health Group Limited (EVE)

EVE Health Group Limited's (EVE) current share price is $0.00. This constitutes a price movement of 0% when compared to the share price 7 days ago and is 0% below EVE's 12-month high of $0.00 per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $0.00, EVE Health Group Limited's (EVE) current share price of $0.00 constitutes a movement of or 0%. EVE Health Group Limited's (EVE) share price movement is 0% when compared to 7 days ago and is 0% below EVE's 52-week high of $0.00.

EVE Health Group Limited's (EVE) 52-week high is $0.00 which was reached on 20 Apr 2023. Relative to this, EVE's current share price of $0.00 constitutes a or 0% drop since that high of $0.00 per EVE share.

EVE Health Group Limited's (EVE) 52-week low is $0.00 which was reached on 20 Apr 2023. Relative to this, EVE's current share price of $0.00 constitutes a or 0% drop since that low of $0.00 per EVE share.

Over the last 12 months, EVE Health Group Limited (EVE) has a daily average trading volume of 467,628 EVE shares per day.

EVE Health Group Limited (EVE) has a current dividend yield of n/a this year. Last year's dividend yield was 0%. The dividend yield for EVE is a ratio that tells you the percentage of EVE Health Group Limited's (EVE) share price that it pays out in dividends each year.

EVE Health Group Limited (EVE) will release its next Annual Report on 27 September 2024. EVE Health Group Limited's (EVE) last annual report was released on 29 Sep 2023. Click here to view EVE Health Group Limited's (EVE) last annual report.

EVE Health Group Limited (EVE) is classified as Consumer Staple. Other companies in this sector include Woolworths Group Limited (WOW), Coles Group Limited (COL), Treasury Wine Estates Limited (TWE), and Endeavour Group Limited (EDV).

The price-to-earnings (P/E) ratio for EVE Health Group Limited (EVE) is 0. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of EVE Health Group Limited's (EVE) share price to its earnings per EVE share.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.